Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Deloitte
Novartis
Merck
US Department of Justice
Baxter
Julphar
McKesson
Covington
Argus Health

Generated: October 21, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Egis

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
1808III8/24/1971REGIS CHEMICAL CO6-HYDROXYDOPAMINE (6-OHDA)
2879III3/3/1977APPLETON PAPER DIV NATIONAL CASH REGISTER CO INCASCOT HEAT SEAL STERILE PACKAGING 1A
3326III10/20/1978EGIS PHARMACEUTICALS PRIVATE LTDALPHA METHYLDOPA USP XIX BULK
4055III2/10/1981EGIS PHARMACEUTICALS PRIVATE LTDCYPROHEPTADINE hcl
4084III2/26/1981EGIS PHARMACEUTICALS PRIVATE LTDALLOPURINOL
4827AII3/3/1983REGIS TECHNOLOGIES INC4-AMINOPYRIDINE
5310III2/13/1984EGIS PHARMACEUTICALS PRIVATE LTDTAMOXIFEN CITRATE
5502III8/1/1984REGIS CHEMICAL COCLORGYLINE (REGIS CODE NO. 002061)
5597III11/9/1984EGIS PHARMACEUTICALS PLCCHLORPROMAZINE HCl
5668III1/23/1985REGIS CHEMICAL COANTIVIROGRAM (DOCUMENT IDENTIFICATION: VIRCO/FDA/98001) IN MECHELEN, BELGIUM.
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Baxter
Deloitte
Federal Trade Commission
Julphar
McKinsey
QuintilesIMS
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot